2m 2m 2m 2m 2m 2m 2m
Elutia-A (ELUT)
NASDAQ
$1.00-$0.04 (-3.85%)
Price as of Jun 03, 2026 4:10 PM EDT- $51.3MMarket Cap
- -46.39%1-Year Change
- Medical DevicesIndustry
Elutia-A (ELUT)
$1.00-$0.04 (-3.85%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 12.3M -49.57% | 24.4M -1.50% | 24.7M -49.69% | 49.2M +3.79% | |
Cost of Revenue | 5.7M -58.32% | 13.7M -0.18% | 13.7M -54.31% | 30.0M +5.63% | |
Gross Profit | 6.6M -38.40% | 10.7M -3.13% | 11.1M -42.50% | 19.2M +1.05% | |
Sales and Marketing Expense | 5.8M -54.05% | 12.5M -4.13% | 13.1M -35.20% | 20.2M +7.28% | |
Research and Development Expense | -4.2M +9.99% | -3.8M -13.96% | -4.4M -50.79% | -8.9M -3.52% | |
Depreciation and Amortization Expense | 2.8M -19.30% | 3.5M -7.92% | 3.7M +0.40% | 3.7M +0.08% | |
Total Operating Expenses | 33.5M -27.72% | 46.4M +11.49% | 41.6M -18.41% | 51.0M +21.18% | |
Operating Profit | -26.9M -24.52% | -35.7M +16.79% | -30.5M -3.82% | -31.7M +37.81% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -5.8M +9.73% | -5.3M -0.79% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -5.8M +9.73% | -5.3M -0.79% | |
Total Nonoperating Income and Expense | -2.8M -332.55% | 1.2M +124.21% | -4.9M -217.79% | 4.2M +16.21% | |
Income before Taxes | -15.9M -70.70% | -54.1M +31.30% | -41.2M +25.43% | -32.9M +32.64% | |
Income Taxes | 13,000 +85.71% | 7,000 -75.00% | 28,000 -17.65% | 34,000 -38.18% | |
Extraordinary Items | 1.4M 0.00% | 1.4M N/A | N/A N/A | N/A N/A | |
Net Income | 53.4M +198.95% | -53.9M +43.27% | -37.7M +14.47% | -32.9M +32.48% | |
Net Income from Continuing Operations Applicable to Common | 40.0M +173.83% | -54.1M +31.30% | -41.2M +25.43% | -32.9M +32.34% | |
Basic EPS and Net Income | 1.29 +169.35% | -1.86 -10.14% | -2.07 -13.03% | -2.38 0.00% | |
Diluted EPS and Net Income | 0.87 +146.77% | -1.86 -10.14% | -2.07 -13.03% | -2.38 0.00% | |
Basic Weighted Average Shares | 41.4M +42.47% | 29.1M +60.08% | 18.2M +31.29% | 13.8M +32.44% | |
Diluted Weighted Average Shares | 45.9M +58.04% | 29.1M +60.08% | 18.2M +31.29% | 13.8M +32.44% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 36.4M +174.57% | 13.2M -31.32% | 19.3M +13.46% | 17.0M -44.10% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 36.4M +174.57% | 13.2M -31.32% | 19.3M +13.46% | 17.0M -44.10% | |
Total Current Assets | 55.8M +113.27% | 26.2M -16.26% | 31.3M -38.36% | 50.7M +6.90% | |
Accumulated Depreciation | 283,000 -55.36% | 634,000 +9.12% | 581,000 -87.75% | 4.7M +6.85% | |
Property and Plant and Equipment and Net | 2.5M +224.84% | 773,000 +349.42% | 172,000 -87.74% | 1.4M +16.92% | |
Total Long-Term Assets | 2.5M +174.15% | 909,000 +173.80% | 332,000 -80.12% | 1.7M +2,097.37% | |
Total Assets | 62.4M +72.59% | 36.1M -16.81% | 43.4M -36.92% | 68.8M +2.49% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 1.3M 0.00% | 1.3M -62.36% | 3.3M -74.10% | 12.8M 0.00% | |
Total Current Liabilities | 25.1M -33.49% | 37.8M -12.18% | 43.0M +0.99% | 42.6M +63.90% | |
Total Long-Term Debt | 22.6M 0.00% | 22.6M +11.04% | 20.4M -16.09% | 24.3M +133.05% | |
Total Long-Term Liabilities | 29.3M +5,592.04% | 515,000 0.00% | 515,000 +305.51% | 127,000 -81.81% | |
Total Liabilities | 34.7M -57.91% | 82.4M +0.44% | 82.0M +11.04% | 73.9M +37.70% | |
Retained Earnings | -176.2M -23.25% | -229.6M +30.71% | -175.6M +27.29% | -138.0M +31.30% | |
Total Stockholders Equity | 27.7M +159.82% | -46.3M +19.84% | -38.6M +666.94% | -5.0M -137.22% | |
Total Shares Outstanding | 42.8M +21.51% | 35.2M +51.79% | 23.2M +43.76% | 16.1M +19.02% | |
Cash Flow | |||||
Cash from Operating Activities | -44.8M +97.78% | -22.7M +4.12% | -21.8M +1.53% | -21.4M +38.77% | |
Capital Expenditures | 1.9M +186.85% | 654,000 +89.02% | 346,000 -35.93% | 540,000 +46.34% | |
Cash from Investing Activities | 78.6M +16,673.63% | -474,000 -103.34% | 14.2M +2,731.11% | -540,000 +46.34% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -10.6M -162.23% | 17.1M +73.72% | 9.8M +15.29% | 8.5M +27.18% | |
Financials Ratio | |||||
Gross Margin | 53.66% +22.15% | 43.93% -1.66% | 44.67% +14.30% | 39.08% -2.64% | |
Operating Margin | -218.91% +49.67% | -146.26% +18.56% | -123.36% +91.17% | -64.53% +32.77% | |
Return on Assets | 108.41% +179.93% | -135.63% +102.18% | -67.08% +38.67% | -48.37% +46.08% | |
Return on Equity | -574.35% -551.72% | 127.15% -26.34% | 172.60% +122.27% | -775.14% +436.16% | |
Revenue Growth | -49.57% +3,214.87% | -1.50% -96.99% | -49.69% -1,410.48% | 3.79% -65.62% | |
Current Ratio | 2.22 +220.64% | 0.69 -4.64% | 0.73 -38.96% | 1.19 -34.78% | |
Cash Ratio | 1.45 +312.79% | 0.35 -21.79% | 0.45 +12.34% | 0.40 -65.89% | |
Debt-to-Equity Ratio | 0.86 +267.18% | -0.52 -15.94% | -0.61 -91.67% | -7.37 -528.81% | |
Debt-to-Assets Ratio | 0.38 -42.06% | 0.66 +21.11% | 0.55 +1.21% | 0.54 +55.74% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow